Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Daily Top 10 COVID-19 papers

DEU | ENG | ESP | FRA | ITA | POR | TUR | VNM


  Vaccines

  Free Subscription


Articles published in Infect Immun

Retrieve available abstracts of 76 articles:
HTML format



Single Articles


    May 2020
  1. JELINSKI J, Terwilliger A, Green S, Maresso A, et al
    Progress Towards the Development of a NEAT Vaccine for Anthrax II: Immunogen Specificity and Alum Effectiveness in an Inhalational Model.
    Infect Immun. 2020 May 11. pii: IAI.00082-20. doi: 10.1128/IAI.00082.
    PubMed     Abstract available


    February 2020
  2. TANG X, Liu X, Suo X
    Towards innovative design and application of recombinant Eimeria as a vaccine vector.
    Infect Immun. 2020 Feb 24. pii: IAI.00861-19. doi: 10.1128/IAI.00861.
    PubMed     Abstract available


    January 2020
  3. NAYAK A, Schuler W, Seidel S, Gomez I, et al
    A broadly protective multivalent OspA vaccine based on surface shaping of the C-terminal fragment.
    Infect Immun. 2020 Jan 13. pii: IAI.00917-19. doi: 10.1128/IAI.00917.
    PubMed     Abstract available


  4. KHALAF OH, Chaki SP, Garcia-Gonzalez DG, Suva LJ, et al
    Interaction of Brucella abortus with osteoclasts: a step towards understanding osteoarticular brucellosis and vaccine safety.
    Infect Immun. 2020 Jan 13. pii: IAI.00822-19. doi: 10.1128/IAI.00822.
    PubMed     Abstract available


    December 2019
  5. MANGAS KM, Buultjens AH, Porter JL, Baines SL, et al
    Vaccine-specific immune responses against Mycobacterium ulcerans infection in a low-dose murine challenge model.
    Infect Immun. 2019 Dec 9. pii: IAI.00753-19. doi: 10.1128/IAI.00753.
    PubMed     Abstract available


  6. LEDBETTER L, Cherla R, Chambers C, Zhang Y, et al
    MHC-II-restricted, CD4(+) T cell-dependent and -independent mechanisms are required for vaccine-induced protective immunity against Coxiella burnetii.
    Infect Immun. 2019 Dec 2. pii: IAI.00824-19. doi: 10.1128/IAI.00824.
    PubMed     Abstract available


  7. MOKRZAN EM, Johnson TJ, Bakaletz LO
    Expression of the Nontypeable Haemophilus influenzae Type IV Pilus Is Stimulated by Coculture with Host Respiratory Tract Epithelial Cells.
    Infect Immun. 2019;87.
    PubMed     Abstract available


  8. GREGORY AE, van Schaik EJ, Russell-Lodrigue KE, Fratzke AP, et al
    Coxiella burnetii Intratracheal Aerosol Infection Model in Mice, Guinea Pigs, and Nonhuman Primates.
    Infect Immun. 2019;87.
    PubMed     Abstract available


    November 2019
  9. HARRO JM, Achermann Y, Freiberg JA, Allison DL, et al
    Clearance of Staphylococcus aureus from In Vivo Models of Chronic Infection by Immunization Requires Both Planktonic and Biofilm Antigens.
    Infect Immun. 2019 Nov 11. pii: IAI.00586-19. doi: 10.1128/IAI.00586.
    PubMed     Abstract available


    October 2019
  10. HERNANDEZ PANDO R, Shin SJ, Clark S, Casonato S, et al
    Construction and characterization of the double unmarked Mycobacterium tuberculosis mutant sigE/fadD26 as a vaccine candidate.
    Infect Immun. 2019 Oct 7. pii: IAI.00496-19. doi: 10.1128/IAI.00496.
    PubMed     Abstract available


  11. SCHOLZEN A, Richard G, Moise L, Hartman E, et al
    Coxiella burnetii Epitope-Specific T-Cell Responses in Patients with Chronic Q Fever.
    Infect Immun. 2019;87.
    PubMed     Abstract available


  12. YOUNT KS, Jennings-Gee J, Caution K, Fullen AR, et al
    Bordetella Colonization Factor A (BcfA) Elicits Protective Immunity against Bordetella bronchiseptica in the Absence of an Additional Adjuvant.
    Infect Immun. 2019;87.
    PubMed     Abstract available


    September 2019
  13. SHIMOJI Y, Ogawa Y, Tsukio M, Shiraiwa K, et al
    Genome-wide identification of virulence genes in Erysipelothrix rhusiopathiae: use of a mutant deficient in a tagF homolog as a safe oral vaccine against swine erysipelas.
    Infect Immun. 2019 Sep 23. pii: IAI.00673-19. doi: 10.1128/IAI.00673.
    PubMed     Abstract available


  14. BI Y, Xu Q, Su L, Xu J, et al
    The combinations-chitosan + Pam3CSK4 and chitosan + MPL: promising immune enhancing adjuvants for anti-caries vaccine PAc.
    Infect Immun. 2019 Sep 16. pii: IAI.00651-19. doi: 10.1128/IAI.00651.
    PubMed     Abstract available


  15. AHMAD S, Bhattacharya D, Kar S, Ranganathan A, et al
    Curcumin Nanoparticles Enhance BCG Vaccine Efficacy by Modulating Host Immune Responses.
    Infect Immun. 2019 Sep 3. pii: IAI.00291-19. doi: 10.1128/IAI.00291.
    PubMed     Abstract available


    August 2019
  16. MACIEL M JR, Bauer D, Baudier RL, Bitoun J, et al
    Intradermal or sublingual delivery and heat-labile enterotoxin (LT) proteins shape immunologic outcomes to CFA/I fimbriae-derived subunit antigen vaccine against enterotoxigenic E. coli.
    Infect Immun. 2019 Aug 19. pii: IAI.00460-19. doi: 10.1128/IAI.00460.
    PubMed     Abstract available


  17. LEDBETTER L, Cherla R, Chambers C, Zhang Y, et al
    Eosinophils affect antibody isotype switching and may partially contribute to early vaccine-induced immunity against Coxiella burnetii.
    Infect Immun. 2019 Aug 19. pii: IAI.00376-19. doi: 10.1128/IAI.00376.
    PubMed     Abstract available


  18. ROGOVSKYY AS, Caoili SEC, Ionov Y, Piontkivska H, et al
    Delineating Surface Epitopes of Lyme Disease Pathogen Targeted by Highly Protective Antibodies of New Zealand White Rabbits.
    Infect Immun. 2019;87.
    PubMed     Abstract available


  19. O'MALLEY KJ, Bowling JD, Barry EM, Hazlett KRO, et al
    Development, Characterization, and Standardization of a Nose-Only Inhalation Exposure System for Exposure of Rabbits to Small-Particle Aerosols Containing Francisella tularensis.
    Infect Immun. 2019;87.
    PubMed     Abstract available


    July 2019
  20. NARITA K, Hu DL, Asano K, Nakane A, et al
    IL-10 produced by mutant toxic shock syndrome toxin-1 vaccine-induced memory T cells downregulates IL-17 production and abrogates the protective effect against Staphylococcus aureus infection.
    Infect Immun. 2019 Jul 29. pii: IAI.00494-19. doi: 10.1128/IAI.00494.
    PubMed     Abstract available


  21. SINGH AK, Curtiss R 3rd, Sun W
    A recombinant attenuated Yersinia pseudotuberculosis vaccine delivering a Y. pestis YopENt138-LcrV fusion elicits broad protection in mice against plague and yersiniosis.
    Infect Immun. 2019 Jul 22. pii: IAI.00296-19. doi: 10.1128/IAI.00296.
    PubMed     Abstract available


  22. ROWE HM, Mann B, Iverson A, Poole A, et al
    A Cross-reactive Protein Vaccine Combined with PCV-13 Prevents Streptococcus pneumoniae- and Haemophilus influenzae-mediated Acute Otitis Media.
    Infect Immun. 2019 Jul 15. pii: IAI.00253-19. doi: 10.1128/IAI.00253.
    PubMed     Abstract available


  23. CHAWLA B, Mahajan B, Oakley M, Majam VF, et al
    Antibody-dependent IFN-gamma-independent sterilizing immunity, induced by a subunit malaria vaccine.
    Infect Immun. 2019 Jul 15. pii: IAI.00236-19. doi: 10.1128/IAI.00236.
    PubMed     Abstract available


  24. DIAZ Y, Govasli ML, Zegeye ED, Sommerfelt H, et al
    Immunizations with Enterotoxigenic Escherichia coli Heat-Stable Toxin Conjugates Engender Toxin-Neutralizing Antibodies in Mice That Also Cross-React with Guanylin and Uroguanylin.
    Infect Immun. 2019;87.
    PubMed     Abstract available


    June 2019
  25. HANSON WG, Benanti EL, Lemmens EE, Liu W, et al
    A potent and effective suicidal Listeria vaccine platform.
    Infect Immun. 2019 Jun 24. pii: IAI.00144-19. doi: 10.1128/IAI.00144.
    PubMed     Abstract available


  26. LOUIS L, Clark M, Wise MC, Glennie N, et al
    Intradermal synDNA vaccination generates Leishmania specific T cells in the skin and protection against Leishmania major.
    Infect Immun. 2019 Jun 10. pii: IAI.00227-19. doi: 10.1128/IAI.00227.
    PubMed     Abstract available


  27. HAYNES AM, Godornes C, Ke W, Giacani L, et al
    Evaluation of the protective ability of the Treponema pallidum subspecies pallidum Tp0126 OmpW homolog in the rabbit model of syphilis.
    Infect Immun. 2019 Jun 10. pii: IAI.00323-19. doi: 10.1128/IAI.00323.
    PubMed     Abstract available


    May 2019
  28. WINTER K, Xing L, Kassardjian A, Ward BJ, et al
    Vaccination against Clostridium difficile using an attenuated Salmonella Typhimurium vector (YS1646) protects mice from lethal challenge.
    Infect Immun. 2019 May 28. pii: IAI.00089-19. doi: 10.1128/IAI.00089.
    PubMed     Abstract available


  29. BLAND SJ, Larabee JL, Shadid TM, Lang ML, et al
    Deletion of a 19-amino acid region in Clostridioides difficile TcdB2 results in spontaneous autoprocessing, reduced cell binding, and provides a non-toxic immunogen for vaccination.
    Infect Immun. 2019 May 28. pii: IAI.00210-19. doi: 10.1128/IAI.00210.
    PubMed     Abstract available


  30. YSEBAERT C, Denoel P, Weynants V, Bakaletz LO, et al
    A Protein E-PilA fusion protein shows vaccine potential against nontypeable Haemophilus influenzae in mice and chinchillas.
    Infect Immun. 2019 May 20. pii: IAI.00345-19. doi: 10.1128/IAI.00345.
    PubMed     Abstract available


  31. BLAIS N, Somers D, Faubert D, Labbe S, et al
    Design and characterization of PE-PilA, a candidate fusion antigen for non-typeable Haemophilus influenzae vaccine.
    Infect Immun. 2019 May 13. pii: IAI.00022-19. doi: 10.1128/IAI.00022.
    PubMed     Abstract available


    April 2019
  32. LEDUC I, Fortney KR, Janowicz DM, Zwickl B, et al
    A class I Haemophilus ducreyi strain containing a class II hgbA allele is partially attenuated in humans: implications for HgbA vaccine efficacy trials.
    Infect Immun. 2019 Apr 29. pii: IAI.00112-19. doi: 10.1128/IAI.00112.
    PubMed     Abstract available


  33. DAVIDS BJ, Liu CM, Hanson EM, Le C, et al
    Identification of conserved candidate vaccine antigens in the surface proteome of Giardia lamblia.
    Infect Immun. 2019 Apr 8. pii: IAI.00219-19. doi: 10.1128/IAI.00219.
    PubMed     Abstract available


  34. ACQUAH FK, Adjah J, Williamson KC, Amoah LE, et al
    Transmission-blocking vaccines: old friends and new prospects.
    Infect Immun. 2019 Apr 8. pii: IAI.00775-18. doi: 10.1128/IAI.00775.
    PubMed     Abstract available


  35. KHALAF OH, Chaki SP, Garcia-Gonzalez DG, Ficht TA, et al
    NOD-scid IL2rgamma(null) Mouse Model is suitable to Study Osteoarticular Brucellosis and Vaccine Safety.
    Infect Immun. 2019 Apr 1. pii: IAI.00901-18. doi: 10.1128/IAI.00901.
    PubMed     Abstract available


  36. YOUNG PG, Raynes JM, Loh JM, Proft T, et al
    Group A Streptococcus T-antigens have a highly conserved structure concealed under a heterogeneous surface that has implications for vaccine design.
    Infect Immun. 2019 Apr 1. pii: IAI.00205-19. doi: 10.1128/IAI.00205.
    PubMed     Abstract available


    March 2019
  37. BEAUDET J, Tulman ER, Pflaum K, Canter JA, et al
    Immunologic Pathways in Protective versus Maladaptive Host Responses to Attenuated and Pathogenic Strains of Mycoplasma gallisepticum.
    Infect Immun. 2019;87.
    PubMed     Abstract available


    February 2019
  38. ALHASSAN A, Liu H, McGill J, Cerezo A, et al
    Rickettsia rickettsii Whole-Cell Antigens Offer Protection against Rocky Mountain Spotted Fever in the Canine Host.
    Infect Immun. 2019;87.
    PubMed     Abstract available


    January 2019
  39. POOLE ST, Maciel M Jr, Dinadayala P, Dori KE, et al
    Biochemical and immunological evaluation of recombinant CS6-derived subunit enterotoxigenic Escherichia coli vaccine candidates.
    Infect Immun. 2019 Jan 2. pii: IAI.00788-18. doi: 10.1128/IAI.00788.
    PubMed     Abstract available


    December 2018
  40. CHAN WY, Entwisle C, Ercoli G, Ramos-Sevillano E, et al
    A novel, multiple-antigen pneumococcal vaccine protects against lethal Streptococcus pneumoniae challenge.
    Infect Immun. 2018 Dec 10. pii: IAI.00846-18. doi: 10.1128/IAI.00846.
    PubMed     Abstract available


  41. ROLLENHAGEN JE, Jones F, Hall E, Maves R, et al
    Establishment, validation and application of a New World Primate model of ETEC disease for vaccine development.
    Infect Immun. 2018 Dec 3. pii: IAI.00634-18. doi: 10.1128/IAI.00634.
    PubMed     Abstract available


    November 2018
  42. TULLIUS MV, Nava S, Horwitz MA
    PPE37 is essential for Mycobacterium tuberculosis heme-iron acquisition (HIA) and a defective PPE37 in Mycobacterium bovis BCG prevents HIA.
    Infect Immun. 2018 Nov 19. pii: IAI.00540-18. doi: 10.1128/IAI.00540.
    PubMed     Abstract available


  43. WANG Y, Wang S, Bouillaut L, Li C, et al
    Oral Immunization with Nontoxigenic Clostridium difficile Strains Expressing Chimeric Fragments of TcdA and TcdB Elicits Protective Immunity against C. difficile Infection in Both Mice and Hamsters.
    Infect Immun. 2018;86.
    PubMed     Abstract available


    September 2018
  44. HIGGINSON EE, Ramachandran G, Panda A, Shipley ST, et al
    Improved tolerability of a Salmonella Typhimurium live-attenuated vaccine strain by balancing inflammatory potential with immunogenicity.
    Infect Immun. 2018 Sep 24. pii: IAI.00440-18. doi: 10.1128/IAI.00440.
    PubMed     Abstract available


  45. CHANDLER CE, Harberts EM, Laemmermann T, Zeng Q, et al
    In Vivo Intradermal Delivery of Bacteria by Using Microneedle Arrays.
    Infect Immun. 2018;86.
    PubMed     Abstract available


  46. LIN YH, Chen Y, Smith TC 2nd, Karna SLR, et al
    Short-Chain Fatty Acids Alter Metabolic and Virulence Attributes of Borrelia burgdorferi.
    Infect Immun. 2018;86.
    PubMed     Abstract available


    August 2018
  47. LU YJ, Oliver E, Zhang F, Pope C, et al
    Screening for Th17-dependent pneumococcal vaccine antigens: comparison of murine and human cellular immune responses.
    Infect Immun. 2018 Aug 27. pii: IAI.00490-18. doi: 10.1128/IAI.00490.
    PubMed     Abstract available


  48. MANI R, Gupta M, Malik A, Tandon R, et al
    Adjuvant Potential of Poly-alpha-L-glutamine from Cell Wall of Mycobacterium tuberculosis.
    Infect Immun. 2018 Aug 13. pii: IAI.00537-18. doi: 10.1128/IAI.00537.
    PubMed     Abstract available


  49. BATOOL M, Caoili SEC, Dangott LJ, Gerasimov E, et al
    Identification of Surface Epitopes Associated with Protection against Highly Immune-Evasive VlsE-Expressing Lyme Disease Spirochetes.
    Infect Immun. 2018;86.
    PubMed     Abstract available


  50. GIUNTINI S, Stoppato M, Sedic M, Ejemel M, et al
    Identification and Characterization of Human Monoclonal Antibodies for Immunoprophylaxis against Enterotoxigenic Escherichia coli Infection.
    Infect Immun. 2018;86.
    PubMed     Abstract available


    July 2018
  51. BOEHM DT, Hall JM, Wong TY, DiVenere A, et al
    Evaluation of adenylate cyclase toxoid antigen in acellular pertussis vaccines using a Bordetella pertussis challenge model in mice.
    Infect Immun. 2018 Jul 16. pii: IAI.00857-17. doi: 10.1128/IAI.00857.
    PubMed     Abstract available


  52. ATCHESON E, Bauza K, Salman AM, Alves E, et al
    Tailoring a P. vivax vaccine to enhance efficacy through a combination of a CSP Virus-Like Particle Rv21 and TRAP viral vectors.
    Infect Immun. 2018 Jul 9. pii: IAI.00114-18. doi: 10.1128/IAI.00114.
    PubMed     Abstract available


  53. BELDE V, Cravens M, Gulandijany D, Walker JA, et al
    Terminal deoxynucleotidyl Transferase is not required for antibody response to polysaccharide vaccines against Streptococcus pneumoniae and Salmonella Typhi.
    Infect Immun. 2018 Jul 2. pii: IAI.00211-18. doi: 10.1128/IAI.00211.
    PubMed     Abstract available


    June 2018
  54. KENNEDY SC, Johnson AJ, Bharrhan S, Lindestam Arlehamn CS, et al
    Identification of mycobacterial ribosomal proteins as targets for CD4(+) T cells that enhance protective immunity in tuberculosis.
    Infect Immun. 2018 Jun 11. pii: IAI.00009-18. doi: 10.1128/IAI.00009.
    PubMed     Abstract available


  55. WANG Y, Wen Z, Pan X, Briles DE, et al
    Novel Immunoprotective Proteins of Streptococcus pneumoniae Identified by Opsonophagocytosis Killing Screen.
    Infect Immun. 2018 Jun 11. pii: IAI.00423-18. doi: 10.1128/IAI.00423.
    PubMed     Abstract available


  56. PELTON SI
    Deconstructing Pneumococcal Progression from Colonization to Disease.
    Infect Immun. 2018;86.
    PubMed     Abstract available


  57. ACQUAYE-SEEDAH E, Reczek EE, Russell HH, DiVenere AM, et al
    Characterization of Individual Human Antibodies That Bind Pertussis Toxin Stimulated by Acellular Immunization.
    Infect Immun. 2018;86.
    PubMed     Abstract available


  58. JENNINGS-GEE J, Quataert S, Ganguly T, D'Agostino R Jr, et al
    The Adjuvant Bordetella Colonization Factor A Attenuates Alum-Induced Th2 Responses and Enhances Bordetella pertussis Clearance from Mouse Lungs.
    Infect Immun. 2018;86.
    PubMed     Abstract available


    May 2018
  59. MOFFITT K, Cheung E, Manis J, Malley R, et al
    Evaluation of the Role of stat3 in Antibody and TH17-Mediated Responses to Pneumococcal Immunization and Infection by Use of a Mouse Model of Autosomal Dominant Hyper-IgE Syndrome.
    Infect Immun. 2018;86.
    PubMed     Abstract available


    April 2018
  60. STYLIANOU E, Harrington-Kandt R, Beglov J, Bull N, et al
    Identification and Evaluation of Novel Protective Antigens for the Development of a Candidate TB Subunit Vaccine.
    Infect Immun. 2018 Apr 16. pii: IAI.00014-18. doi: 10.1128/IAI.00014.
    PubMed     Abstract available


  61. QUEMENEUR L, Petiot N, Arnaud-Barbe N, Hessler C, et al
    Clostridium difficile toxoid vaccine candidate confers broad protection against a range of prevalent circulating strains in a non-clinical setting.
    Infect Immun. 2018 Apr 9. pii: IAI.00742-17. doi: 10.1128/IAI.00742.
    PubMed     Abstract available


  62. YU J, Li B, Chen X, Lu J, et al
    Comparison of immunogenicity and protection of two pneumococal protein vaccines based on PsaA and PspA.
    Infect Immun. 2018 Apr 2. pii: IAI.00916-17. doi: 10.1128/IAI.00916.
    PubMed     Abstract available


    March 2018
  63. SERRADELL MC, Gargantini PR, Saura A, Oms SR, et al
    Cytokines, antibodies and histopathological profiles during Giardia infection and VSP-based vaccination.
    Infect Immun. 2018 Mar 19. pii: IAI.00773-17. doi: 10.1128/IAI.00773.
    PubMed     Abstract available


    February 2018
  64. OLSEN RW, Ecklu-Mensah G, Bengtsson A, Ofori MF, et al
    Natural and vaccine-induced acquisition of cross-reactive IgG inhibiting ICAM-1-specific binding of a PfEMP1 subtype associated specifically with cerebral malaria.
    Infect Immun. 2018 Feb 5. pii: IAI.00622-17. doi: 10.1128/IAI.00622.
    PubMed     Abstract available


    January 2018
  65. JONES K, Versteeg L, Damania A, Keegan B, et al
    Vaccine-linked chemotherapy improves benznidazole efficacy for acute Chagas disease.
    Infect Immun. 2018 Jan 8. pii: IAI.00876-17. doi: 10.1128/IAI.00876.
    PubMed     Abstract available


  66. MARTINEZ-BECERRA FJ, Kumar P, Vishwakarma V, Kim JH, et al
    Characterization and protective efficacy of type three secretion proteins as a broadly protective subunit vaccine against Salmonella enterica serovars.
    Infect Immun. 2018 Jan 8. pii: IAI.00473-17. doi: 10.1128/IAI.00473.
    PubMed     Abstract available


    December 2017
  67. BROCKMEIER SL, Loving CL, Nicholson TL, Wang J, et al
    Use of proteins identified through a functional genomic screen to develop a protein subunit vaccine that provides significant protection against virulent Streptococcus suis in pigs.
    Infect Immun. 2017 Dec 4. pii: IAI.00559-17. doi: 10.1128/IAI.00559.
    PubMed     Abstract available


  68. PEREZ AC, Johnson A, Chen Z, Wilding GE, et al
    Mapping protective regions on a three-dimensional model of the Moraxella catarrhalis vaccine antigen, Oligopeptide Permease A.
    Infect Immun. 2017 Dec 4. pii: IAI.00652-17. doi: 10.1128/IAI.00652.
    PubMed     Abstract available


  69. LADDY DJ, Bonavia A, Hanekom WA, Kaushal D, et al
    Toward Tuberculosis Vaccine Development: Recommendations for NHP Study Design.
    Infect Immun. 2017 Dec 4. pii: IAI.00776-17. doi: 10.1128/IAI.00776.
    PubMed     Abstract available


    November 2017
  70. WANG L, Zhu C, Zhang T, Tian Q, et al
    Non-pathogenic colonization with Chlamydia in the gastrointestinal tract as oral vaccination for inducing transmucosal protection.
    Infect Immun. 2017 Nov 13. pii: IAI.00630-17. doi: 10.1128/IAI.00630.
    PubMed     Abstract available


  71. BURTNICK MN, Shaffer TL, Ross BN, Muruato LA, et al
    Development of Subunit Vaccines that Provide High Level Protection and Sterilizing Immunity Against Acute Inhalational Melioidosis.
    Infect Immun. 2017 Nov 6. pii: IAI.00724-17. doi: 10.1128/IAI.00724.
    PubMed     Abstract available


    October 2017
  72. PAL S, Tifrea DF, Zhong G, de la Maza LM, et al
    Transcervical inoculation with Chlamydia trachomatis induces infertility in HLA-DR4-transgenic and wild type mice.
    Infect Immun. 2017 Oct 16. pii: IAI.00722-17. doi: 10.1128/IAI.00722.
    PubMed     Abstract available


  73. PARZYCH EM, Miura K, Ramanathan A, Long CA, et al
    Evaluation of a Plasmodium-specific carrier protein to enhance production of recombinant Pfs25, a leading transmission-blocking vaccine candidate.
    Infect Immun. 2017 Oct 9. pii: IAI.00486-17. doi: 10.1128/IAI.00486.
    PubMed     Abstract available


    September 2017
  74. LACEY KA, Leech JM, Lalor SJ, McCormack N, et al
    The Staphylococcus aureus cell wall-anchored protein clumping factor A is an important T cell antigen.
    Infect Immun. 2017 Sep 25. pii: IAI.00549-17. doi: 10.1128/IAI.00549.
    PubMed     Abstract available


  75. SEVASTSYANOVICH YR, Withers DR, Marriott CL, Morris FC, et al
    Antigen localisation influences the magnitude and kinetics of the endogenous adaptive immune response to recombinant Salmonella vaccines.
    Infect Immun. 2017 Sep 11. pii: IAI.00593-17. doi: 10.1128/IAI.00593.
    PubMed     Abstract available


    March 2017
  76. LEES JA, Brouwer M, van der Ende A, Parkhill J, et al
    Within-Host Sampling of a Natural Population Shows Signs of Selection on Pde1 during Bacterial Meningitis.
    Infect Immun. 2017;85.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: